KUNKL, ANNALISA
 Distribuzione geografica
Continente #
EU - Europa 985
AS - Asia 141
NA - Nord America 58
SA - Sud America 12
AF - Africa 3
OC - Oceania 1
Totale 1.200
Nazione #
IT - Italia 957
SG - Singapore 65
US - Stati Uniti d'America 52
CN - Cina 38
VN - Vietnam 25
FI - Finlandia 11
BR - Brasile 9
FR - Francia 7
CA - Canada 5
BD - Bangladesh 2
CY - Cipro 2
IN - India 2
PH - Filippine 2
VE - Venezuela 2
AO - Angola 1
AR - Argentina 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
DE - Germania 1
DO - Repubblica Dominicana 1
ES - Italia 1
GB - Regno Unito 1
GR - Grecia 1
HK - Hong Kong 1
IQ - Iraq 1
KW - Kuwait 1
MA - Marocco 1
NL - Olanda 1
PL - Polonia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TZ - Tanzania 1
UA - Ucraina 1
Totale 1.200
Città #
Genoa 431
Genova 334
Rapallo 112
Vado Ligure 69
Singapore 39
San Jose 23
Helsinki 11
Ashburn 9
Hanoi 9
Beijing 8
Ho Chi Minh City 4
Lauterbourg 4
Santa Clara 3
Da Nang 2
Montreal 2
Nicosia 2
Paris 2
Phủ Lý 2
Toronto 2
Acalanes Ridge 1
Amsterdam 1
As Sālimīyah 1
Athens 1
Baku 1
Barquisimeto 1
Belo Horizonte 1
Bertioga 1
Biên Hòa 1
Bordighera 1
Bratislava 1
Calamba 1
Chennai 1
City of London 1
Council Bluffs 1
Curitiba 1
Dallas 1
Dar es Salaam 1
Erbil 1
Frankfurt am Main 1
Haikou 1
Haiphong 1
Hat Yai 1
Hong Kong 1
Hortolândia 1
Itu 1
Khouribga 1
Ljubljana 1
Long An 1
Lorena 1
Luanda 1
Macapá 1
Madrid 1
Maracaibo 1
Marseille 1
Milltown 1
Molfetta 1
New York 1
Paraty 1
Saint Albans 1
San Juan 1
Santiago de los Caballeros 1
Seattle 1
Shanghai 1
Staten Island 1
Stockton 1
Sydney 1
Sátiro Dias 1
Thanh Hóa 1
Tianjin 1
Vancouver 1
Vĩnh Tường 1
Warsaw 1
Totale 1.121
Nome #
A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia 218
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients 211
Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia 189
Clinical scale ex vivo expansion of cord blood-derived outgrowth endothelial progenitor cells is associated with high incidence of karyotype aberrations. 185
Amniotic fluid contains multipotent mesenchymal stromal cells with high proliferative potential and safety features: solid perspectives for clinical application 160
A Blastic Plasmacytoid Dendritic Cell Neoplasm-like Phenotype Identifies a Subgroup of NPM1-Mutated AML Patients with Worse Prognosis While Has Not Predictive Value in NPM1-Wt AML 111
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation 89
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 59
Totale 1.222
Categoria #
all - tutte 3.813
article - articoli 3.813
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 4 17 10
2021/202274 1 3 5 10 2 10 1 12 6 7 2 15
2022/2023132 11 15 2 18 22 20 0 5 13 7 19 0
2023/202486 1 10 1 9 7 19 3 18 3 3 6 6
2024/2025270 8 14 6 15 11 23 40 69 8 14 28 34
2025/2026380 64 12 23 55 52 24 56 21 37 36 0 0
Totale 1.222